Abstract
Globalisation will have an adverse effect on access to drugs as far as developing countries are concerned because when the Trade Related Intellectual Property Rights (TRIPS) Agreement comes into operation in 2005 the prices of drugs for which patents are in place will increase. However, this effect can be reduced if timely steps are taken to aggressively introduce programmes of rational use of drugs and the country enacts legislation to take advantage of the possible safe guards that have been incorporated into the TRIPS Agreement.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
